Galectin Therapeutics
(NASDAQ:GALT)
$3.40
0.02[0.59%]
At close: Apr 18
$3.40
0[0.00%]
PreMarket: 9:28AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Galectin Therapeutics Stock (NASDAQ:GALT), Quotes and News Summary

Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 136.765K
Day Range- - -
52 Wk Range1.280 - 4.268
Market Cap$210.472M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
60
Short Interest
7.59%
Days to Cover18.26

Recent News

Galectin Therapeutics And 3 Other Stocks Under $2 Insiders Are Buying
The Dow Jones closed higher by more than 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
$7M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
Around $30 Million Bet On This Communication Services Stock? 4 Penny Stocks Insiders Are Buying
The Dow Jones gained by more than 300 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Galectin Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GALT
OTLK

FAQ

Q

How do I buy Galectin Therapeutics (GALT) stock?

A

You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Galectin Therapeutics's (GALT) competitors?

A

Other companies in Galectin Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), Adaptimmune Therapeutics (NASDAQ:ADAP) and Abeona Therapeutics (NASDAQ:ABEO).

Q

What is the target price for Galectin Therapeutics (GALT) stock?

A

The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on Tuesday, April 9, 2024. The analyst firm set a price target for 11.00 expecting GALT to rise to within 12 months (a possible 223.53% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Galectin Therapeutics (GALT)?

A

The stock price for Galectin Therapeutics (NASDAQ: GALT) is $3.4 last updated April 18, 2024 at 9:28 AM EDT.

Q

Does Galectin Therapeutics (GALT) pay a dividend?

A

There are no upcoming dividends for Galectin Therapeutics.

Q

When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?

A

Galectin Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Galectin Therapeutics (GALT) going to split?

A

There is no upcoming split for Galectin Therapeutics.

Q

What sector and industry does Galectin Therapeutics (GALT) operate in?

A

Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch